Clinical Trials
2 trialsNCT07355699 2026-01-21
Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
Beijing Tongren Hospital
Phase 4 Recruiting
NCT06134284 2024-06-11
Clinical Study of OR for Second-line Treatment of Refractory MZL
Ningbo No. 1 Hospital
Phase 4 Recruiting